375 related articles for article (PubMed ID: 18279363)
1. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain.
Keller M; Griesmaier E; Auer M; Schlager G; Urbanek M; Simbruner G; Gressens P; Sárközy G
Eur J Neurosci; 2008 Feb; 27(4):874-83. PubMed ID: 18279363
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice.
Griesmaier E; Posod A; Gross M; Neubauer V; Wegleiter K; Hermann M; Urbanek M; Keller M; Kiechl-Kohlendorfer U
Exp Neurol; 2012 Oct; 237(2):388-95. PubMed ID: 22771763
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.
Liu Y; Qin L; Li G; Zhang W; An L; Liu B; Hong JS
J Pharmacol Exp Ther; 2003 Apr; 305(1):212-8. PubMed ID: 12649371
[TBL] [Abstract][Full Text] [Related]
4. Ontogenic study of the influence of tissue plasminogen activator (t-PA) in neonatal excitotoxic brain insult and the subsequent microglia/macrophage activation.
Hennebert O; Laudenbach V; Laquerriere A; Verney C; Carmeliet P; Marret S; Leroux P
Neuroscience; 2005; 130(3):697-712. PubMed ID: 15590153
[TBL] [Abstract][Full Text] [Related]
5. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
[TBL] [Abstract][Full Text] [Related]
6. T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice.
Sárközy G; Griesmaier E; He X; Kapelari K; Urbanek M; Simbruner G; Gressens P; Keller M
Eur J Paediatr Neurol; 2007 May; 11(3):129-35. PubMed ID: 17222575
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice.
Keller M; Yang J; Griesmaier E; Gorna A; Sarkozy G; Urbanek M; Gressens P; Simbruner G
Neurobiol Dis; 2006 Nov; 24(2):357-66. PubMed ID: 16959492
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of NAP against excitotoxic brain damage in the newborn mice: implications for cerebral palsy.
Sokolowska P; Passemard S; Mok A; Schwendimann L; Gozes I; Gressens P
Neuroscience; 2011 Jan; 173():156-68. PubMed ID: 21073926
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects vary across nonsteroidal antiinflammatory drugs in a mouse model of developing excitotoxic brain injury.
Leroux P; Hennebert C; Catteau J; Legros H; Hennebert O; Laudenbach V; Marret S
Neuroscience; 2010 May; 167(3):716-23. PubMed ID: 20188153
[TBL] [Abstract][Full Text] [Related]
10. The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial membrane potential in vitro and inhibiting microglial activation in vivo.
Wegleiter K; Hermann M; Posod A; Wechselberger K; Stanika RI; Obermair GJ; Kiechl-Kohlendorfer U; Urbanek M; Griesmaier E
Exp Neurol; 2014 Nov; 261():501-9. PubMed ID: 25111531
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties.
Husson I; Mesplès B; Medja F; Leroux P; Kosofsky B; Gressens P
Neuroscience; 2004; 125(1):163-70. PubMed ID: 15051155
[TBL] [Abstract][Full Text] [Related]
12. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype.
Paris A; Mantz J; Tonner PH; Hein L; Brede M; Gressens P
Anesth Analg; 2006 Feb; 102(2):456-61. PubMed ID: 16428542
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
Tortella FC; Britton P; Williams A; Lu XC; Newman AH
J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
[TBL] [Abstract][Full Text] [Related]
14. The common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury.
Posod A; Pinzer K; Urbanek M; Wegleiter K; Keller M; Kiechl-Kohlendorfer U; Griesmaier E
Neuroscience; 2014 Aug; 274():260-72. PubMed ID: 24912029
[TBL] [Abstract][Full Text] [Related]
15. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity.
Chen CM; Lin JK; Liu SH; Lin-Shiau SY
J Neurosci Res; 2008 Sep; 86(12):2696-704. PubMed ID: 18478543
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept.
Adén U; Favrais G; Plaisant F; Winerdal M; Felderhoff-Mueser U; Lampa J; Lelièvre V; Gressens P
Brain Behav Immun; 2010 Jul; 24(5):747-58. PubMed ID: 19861157
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
Werling LL; Lauterbach EC; Calef U
Neurologist; 2007 Sep; 13(5):272-93. PubMed ID: 17848867
[TBL] [Abstract][Full Text] [Related]
18. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice.
Medja F; Lelièvre V; Fontaine RH; Lebas F; Leroux P; Ouimet T; Saria A; Rougeot C; Dournaud P; Gressens P
Brain; 2006 Dec; 129(Pt 12):3209-23. PubMed ID: 17028311
[TBL] [Abstract][Full Text] [Related]
19. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.
Keller M; Simbruner G; Górna A; Urbanek M; Tinhofer I; Griesmaier E; Sarkozy G; Schwendimann L; Gressens P
Pediatr Res; 2006 Apr; 59(4 Pt 1):549-53. PubMed ID: 16549527
[TBL] [Abstract][Full Text] [Related]
20. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits.
Fredriksson A; Pontén E; Gordh T; Eriksson P
Anesthesiology; 2007 Sep; 107(3):427-36. PubMed ID: 17721245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
